English हिन्दी
Connect with us

Latest Science News

Israel cancer cure claim debunked by experts

Published

on

[vc_row][vc_column][vc_column_text]The Israeli biotech company, Accelerated Evolution Biotechnologies (AEBi), has announced a medical breakthrough that will cure cancer.
The company claimed that they will have the cure for this deadly disease by 2020.
Dan Aridor, of the firm Accelerated Evolution Biotechnologies Ltd. (AEBi) behind the claims, told The Jerusalem Post: “We believe we will offer in a year’s time a complete cure for cancer.”
“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” he said. “Our solution will be both generic and personal.”
The treatment called MuTaTo (a portmanteau of multi-target toxin), is based around small fragments of proteins called peptides, designed to target cancer cells.
Dr. Ilan Morad, CEO of AEBi, which is based at the Weizmann Science Park, Israel, explained to The Jerusalem Post that some existing cancer treatments hone in on targets “on or in the cancer cell.” But if the cell mutates, the treatment can become ineffective.
According to Morad, MuTaTo features a trio of peptides and a toxin that launch a three-pronged attack on cancer receptor proteins. The treatment could also have the potential to obliterate slow-growing cancer stem cells, which drugs designed to kill faster cells, can fail to, he said.
“We believe we will offer in a year’s time a complete cure for cancer,” said Aridor.
Morad said the firm had carried out in-vitro and mice experiments, and is set to launch clinical trials.
It was not clear if their results had been published in a peer-reviewed medical journal.
The news of such a big discovery spread online, other cancer experts urged the public to approach the report with caution.
Many experts who are doing research on this topic for a long period of time shared their views.
Dr. Darren Saunders, a cancer biologist at the University of New South Wales, Australia, tweeted the researchers were “selling unicorns.”


Professor Lawrence Young, director of the Warwick Cancer Research Centre at the University of Warwick, U.K., told Newsweek he was concerned the team had not appeared to publish their data in a peer-reviewed journal, and that no clinical trials had been performed. Such trials are the first step outside of the laboratory in drug development.
As per report by Newsweek, Julia Frater, senior cancer information nurse at the charity Cancer Research UK, “Unsubstantiated claims that there will be a cure for all cancers in a year are irresponsible and can be misleading for patients. This oversimplifies the fact that cancer is more than 200 different diseases, which behave differently and pose different treatment challenges. This is why finding a single cure for all cancers is unlikely.”
Professor Chris Bunce, who specializes in translational cancer biology at the University of Birmingham, U.K., told Newsweek that widely used treatments such as chemotherapy were previously regarded as “radical” and said the “technology being talked about here may be another step in that journey.”
Bunce explained why creating cancer drugs is so difficult. “On one hand cancer cells are not the big scary monsters that the general public believes them to be. More than 99.9 percent of the molecular processes within them are the same as the normal cells they originate from. So finding drugs that only target cancer cells is like finding needles in haystacks.
(Inputs from media sources)[/vc_column_text][/vc_column][/vc_row]

India News

NASA astronauts Sunita Williams, Nick Hague step outside spacecraft after 7 months

Williams’ extensive experience continues to shine during these demanding missions, highlighting the resilience and skill required for space exploration.

Published

on

NASA astronauts Sunita Williams and Nick Hague stepped outside the International Space Station (ISS) today for a vital mission, marking Williams’ eighth spacewalk and Hague’s fourth. Their objective focused on essential repairs, showcasing their expertise and commitment to the job.

The spacewalk, designated US Spacewalk 91, took place on January 16, 2025. This was Williams’ first spacewalk in 12 years, while Hague added a fourth accomplishment to his impressive track record. Together, they initiated a six-and-a-half-hour operation aimed at repairing critical systems on the ISS.

Their tasks included maintaining equipment for the station’s orientation, upgrading the Neutron Star Interior Composition ExploreR (NICER) telescope, and replacing a reflector on a docking adapter, as well as preparing tools for future work on the ISS. Williams, an accomplished astronaut, expressed her enthusiasm as she exited the station by radioing, “I’m coming out,” signalling her return to spacewalking duties.

Williams and her fellow astronaut Butch Wilmore were initially scheduled to return in June 2024 after a week-long mission aboard Boeing’s Starliner, but technical issues with the spacecraft forced an extended stay. NASA has since rescheduled their return for March or April. Additionally, safety concerns related to SpaceX’s Crew-10 mission have further delayed their plans. Nevertheless, the astronauts have adjusted well to life aboard the ISS.

NASA’s Flight Director, Nicole McElroy, commended the crew for their thorough preparations for the spacewalks. “The crew has studied the tasks and is fully ready,” McElroy noted.

https://twitter.com/Space_Station/status/1879916338527002938

Williams will join Wilmore for another spacewalk next week, where they will focus on removing an antenna assembly and collecting surface samples to study microorganisms on the station’s exterior. They will also prepare a spare elbow joint for the Canadarm2 robotic arm. NASA emphasizes that these activities are crucial for the upkeep of the station, with each spacewalk anticipated to last around six and a half hours.

Williams’ extensive experience continues to shine during these demanding missions, highlighting the resilience and skill required for space exploration.

Continue Reading

India News

ISRO successfully completes SpaDeX docking experiment, joins global elite in space technology

Published

on

ISRO SpaDeX mission demonstrating satellite docking for India’s space station

The Indian Space Research Organisation (ISRO) has successfully conducted the SpaDeX docking experiment, marking a significant advancement in India’s space capabilities. Early on Thursday, January 16, 2025, ISRO joined the ranks of the USA, Russia, and China by mastering the complex technology required for spacecraft docking in orbit.

Launched on December 30, 2024, by the PSLV C60, the two satellites involved in the experiment, SDX01 (Chaser) and SDX02 (Target), reached their designated positions and executed a flawless docking maneuver. This operation was closely monitored by the team at ISRO’s Mission Operations Complex (MOX) at the Telemetry, Tracking, and Command Network (ISTRAC).

Celebrating this achievement, ISRO shared on social media, “Docking Success Spacecraft docking successfully completed! A historic moment. India became the 4th country to achieve successful space docking. Congratulations to the entire team!”

Following the successful docking, ISRO has maintained control over the newly unified satellite structure and plans to conduct undocking and power transfer tests in the forthcoming days. This mission, beyond its immediate success, aims to lay the groundwork for more ambitious endeavors such as manned lunar missions, sample returns from the moon, and potentially an Indian Space Station.

The SpaDeX mission also serves as a demonstration of vital technologies like electrical power transfer between docked spacecraft, which will be crucial for future in-space robotic operations and composite spacecraft management post-undocking.

ISRO stated that the next steps involve validating the docking process through ground simulations and ensuring the mission’s objectives continue smoothly with subsequent experiments planned over the mission’s expected life span of up to two years.

This milestone not only demonstrates ISRO’s growing capabilities in space technology but also promises to bolster India’s position in future international space exploration initiatives.

Continue Reading

Latest Science News

SpaDeX Mission: A key milestone in India’s path to the Bharatiya Antriksh Station

Published

on

ISRO SpaDeX mission demonstrating satellite docking for India’s space station

In a historic step towards establishing its own space station, the Indian Space Research Organisation (ISRO) launched the Space Docking Experiment (SpaDeX) from Sriharikota on December 30, 2024. This groundbreaking mission aims to demonstrate India’s capability to dock two satellites in orbit, a feat achieved so far only by the United States, Russia, and China.

The SpaDeX mission, executed aboard the reliable PSLV-C60 rocket, successfully deployed two spacecraft, SDX01 and SDX02, into a low-Earth orbit approximately 475 kilometers above Earth. Over the following days, these satellites, designated as the “Chaser” and the “Target,” will perform precise maneuvers for docking, undocking, and interlocking, with real-time control by ISRO scientists in Bengaluru.

A leap towards Bharatiya Antriksh Station

SpaDeX is integral to India’s ambitious space station project, the Bharatiya Antriksh Station, slated for completion by 2035. The mission marks a significant step in developing technologies for rendezvous and docking, essential for constructing and operating a space station.

Currently, only two space stations exist—the International Space Station (ISS), a collaboration between NASA, Roscosmos, and ESA, and China’s Tiangong Space Station. With Bharatiya Antriksh Station, India aspires to join this elite league.

Critical objectives of SpaDeX

The primary goals of SpaDeX include:

  1. Demonstrating docking technology to ensure seamless interlocking and pressure checks between spacecraft.
  2. Electric power transfer between docked spacecraft, paving the way for advanced in-space operations.
  3. Composite spacecraft control, enabling remote and automated management from mission control.
  4. Payload experiments post-undocking, ensuring optimal utilization of resources.

These advancements will also enhance the docking capability of India’s Reusable Launch Vehicle (RLV), akin to NASA’s space shuttles, for future missions.

Microgravity experiments with POEM-4

In tandem with SpaDeX, ISRO is conducting microgravity experiments using the PSLV’s fourth stage, termed POEM-4 (PSLV Orbital Experimental Module-4). This platform hosts 24 payloads, including a robotic arm to simulate debris capture—a crucial capability for future space station operations.

The microgravity experiments will benefit academia, startups, and ISRO’s own research centers, providing invaluable insights for extended-duration missions.

Inspiration from “Interstellar”

Docking in space is a complex maneuver, vividly dramatized in the sci-fi film Interstellar. Similar to the movie’s high-stakes scenario, ISRO’s mission involves the Chaser spacecraft approaching and interlocking with the Target while both orbit Earth at high speeds.

Pioneering India’s space future

The SpaDeX mission is not just a technological milestone but a testament to India’s growing prowess in space exploration. If successful, it will cement India’s position as a leader in cutting-edge space technology, bringing the nation closer to realizing its space station dream.

By leveraging such innovations, ISRO continues to push boundaries, inspiring the next generation of scientists and contributing to global advancements in space research.

Continue Reading

Trending

© Copyright 2022 APNLIVE.com